'Clinical trials for Ayurveda dengue drug in advanced stages'

Image
Press Trust of India New Delhi
Last Updated : Oct 19 2016 | 9:07 PM IST
Clinical trials for Ayurveda-based drug for dengue, jointly being carried out by the Indian Council of Medical Research and the Ministry of AYUSH, are in the "advanced stages" and presently its clinical safety and efficacy is being tested, senior officials today said.
Central Council for Research in Ayurvedic Sciences (CCRAS), an autonomous body under the Ministry of AYUSH and ICMR's regional research centre in Belgaum in Karnataka are carrying out the trials.
"Clinical trials on dengue drug are in advanced stages. CCRAS and ICMR are conducting it in Belgaum to test the clinical safety and efficacy. The drug had earlier been standarised and after we got positive leads on it last year, we decided to go for the trials," Joint Secretary, AYUSH Ministry, A K Ganeriwala, said.
He said, if thing go as planned, the "drug should be out by next dengue season."
Director General of ICMR Soumya Swaminathan said, "our partnership in the trials would mean that the claims of efficacy of Ayurveda drugs would be validated scientifically."
"The advanced stages of the trials began few weeks ago at our research facility in Begaum," she said.
Asked if any similar trials could be done for chikungunya, she said, "it could be taken up".
Ganeriwala said the trials had begun almost a year ago and went through various stages.
A senior official at AYUSH Ministry said, "In ancient texts like 'Charak Sanhita', the concept of 'jwara (fever) and its cure has been mentioned, though dengue or chikungunya doesn't find a mention, as the nomenclature came up in last several decades.
"But, since, the treatment of these diseases are symptomatic, the trials have helped assess the efficacy of the drug. ICMR association means that the impact of drug on patients would be scientifically validated and put through a rigorous scrutiny. And, once it is done, then we can think of transferring the technology to commercial entities," he said.
Currently there is no drug for dengue in India.
At least 21 deaths due to dengue have been reported at various hospitals in Delhi, including nine at AIIMS, while over 3,000 people have been afflicted by the vector-borne disease in the national capital.
According to National Vector Borne Disease Control Programme (NVBDCP), 51,731 dengue cases have been reported till October 2 across the county, and 93 people have died due to it.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 19 2016 | 9:07 PM IST

Next Story